Beam Therapeutics Inc
(BEAM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -99,128 | -64,676 | -30,458 | -78,326 | -50,476 |
| Depreciation Amortization | 3,512 | 2,141 | 971 | 2,583 | 1,831 |
| Accounts payable and accrued liabilities | -134 | -53 | -471 | 4,092 | 1,321 |
| Other Working Capital | 10,953 | 6,997 | -962 | -3,401 | -10,642 |
| Other Operating Activity | 13,354 | 5,361 | 3,527 | 3,049 | 3,763 |
| Operating Cash Flow | $-71,443 | $-50,230 | $-27,393 | $-72,003 | $-54,203 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,232 | -5,413 | -3,046 | -12,518 | -10,358 |
| Purchase Of Investment | -167,844 | -136,709 | -118,469 | -130,210 | -111,824 |
| Sale Of Investment | 157,380 | 88,198 | 44,723 | 76,069 | 38,964 |
| Investing Cash Flow | $-18,696 | $-53,924 | $-76,792 | $-66,659 | $-83,218 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,069 | 512 | 152 | 185 | 136 |
| Other Financing Activity | 191,260 | 191,723 | 192,862 | 41,094 | 40,444 |
| Financing Cash Flow | $192,329 | $192,235 | $193,014 | $41,279 | $40,580 |
| Beginning Cash Position | 50,553 | 50,553 | 50,553 | 147,936 | 147,936 |
| End Cash Position | 152,743 | 138,634 | 139,382 | 50,553 | 51,095 |
| Net Cash Flow | $102,190 | $88,081 | $88,829 | $-97,383 | $-96,841 |
| Free Cash Flow | |||||
| Operating Cash Flow | -71,443 | -50,230 | -27,393 | -72,003 | -54,203 |
| Capital Expenditure | -8,232 | -5,413 | -3,046 | -12,518 | -10,358 |
| Free Cash Flow | -79,675 | -55,643 | -30,439 | -84,521 | -64,561 |